Ultiva

Active Ingredient(s): Remifentanil
FDA Approved: * July 12, 1996
Pharm Company: * ABBOTT
Category: Pain Relief

Remifentanil is a potent, short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. Remifentanil is used for sedation as well as combined with other medications for use in general anesthesia. The use of remifentanil has made possible the use of high-dose opioid and low-dose hypnotic anesthesia, due to synergism between remifentanil and various hypnotic drugs and volatile anesthetics. Contents 1 Clinical use 2... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67457-198
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67457-912
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67457-913
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67457-914
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 72078-034
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 72078-035
Labeler:
Mylan Institutional LLC
Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 72078-036
Labeler:
Mylan Institutional LLC